Operating Lease, Liability of Zivo Bioscience, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Zivo Bioscience, Inc. quarterly Operating Lease, Liability in USD history and change rate from 31 Dec 2020 to 30 Sep 2025.
Zivo Bioscience, Inc. Operating Lease, Liability for the quarter ending 30 Sep 2025 was $285,837.
Source SEC data: View on sec.gov

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Change (%)

Zivo Bioscience, Inc. Quarterly Operating Lease, Liability (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$285,837			30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$300,742			30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$315,247			31 Mar 2025	10-Q	15 May 2025	2025	Q1
Q4 2024	$0	-$106,342	-100%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q4 2023	$106,342	-$98,836	-48%	31 Dec 2023	10-K	18 Mar 2025	2024	FY
Q3 2023	$132,425	-$92,209	-41%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$157,607	-$85,761	-35%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q4 2022	$205,178	+$190,000	+1252%	31 Dec 2022	10-K	15 Mar 2024	2023	FY
Q3 2022	$224,634	+$200,170	+818%	30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$243,368	+$209,869	+626%	30 Jun 2022	10-Q	04 Aug 2022	2022	Q2
Q1 2022	$211,167	+$195,989	+1291%	31 Mar 2022	10-Q	13 May 2022	2022	Q1
Q4 2021	$15,178	-$29,172	-66%	31 Dec 2021	10-K	14 Mar 2023	2022	FY
Q3 2021	$24,464			30 Sep 2021	10-Q/A	21 Apr 2022	2021	Q3
Q2 2021	$33,499			30 Jun 2021	10-Q	16 Aug 2021	2021	Q2
Q1 2021	$15,178			31 Mar 2021	10-Q	13 May 2022	2022	Q1
Q4 2020	$44,350			31 Dec 2020	10-K	22 Apr 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.